shRNA interference for extracellular signal-regulated kinase 2 can inhibit the growth of esophageal cancer cell line Eca109

References

• Parkin DM, Bray FI, Devesa SS.Cancer burden in the year 2000 the global picture. Eur J Cancer 2001, 37, S4S66.
   Google Scholar
• Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001, 22, 1737–1746.
   PubMed Web of Science ®Google Scholar
• Stoner GD, Wang LS, Chen T. Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 2007, 224, 337–349.
   PubMed Web of Science ®Google Scholar
• Umar SB, Fleischer DE. Esophageal cancer: epidemiology, pathogenesis and prevetion. Gastroen Hepatology 2008, 5, 517–526.
   Google Scholar
• Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 2008, 22, 954–965.
   PubMed Web of Science ®Google Scholar
• McKay MM, Morrison DK. Integrating signals from RTKs to ERK/MAPK. Oncogene 2007, 26, 3113–3121.
   PubMed Web of Science ®Google Scholar
• Zeng PY, Wagoner HA, Pescovitz OH, Steinmet R. RNA interference (RNAi) for extracellular signal-regulated kinase 1 (ERK1) alone is sufficient to suppress cell viability in ovarian cancer cells. Cancer Biol Ther 2005, 4, 961–967.
   PubMed Web of Science ®Google Scholar
• Bhalla US, Ram PT, Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 2002, 297, 1018–1023.
   PubMed Web of Science ®Google Scholar
• Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van Belle P, Elder DE, Herlyn M. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 2003, 63, 756–759.
   PubMed Web of Science ®Google Scholar
• Barry OP, Mullan B, Sheehan D, Kazanietz MG, Shanahan F, Collins JK, O’Sullivan GC. Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent. J Biol Chem 2001, 276, 15537–15546.
   PubMedGoogle Scholar
• Sivaraman VS, Wang H, Nuovo GJ, Malbon CC. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997, 99, 1478–1483.
   PubMed Web of Science ®Google Scholar
• Ballif BA, Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 2001, 12, 397–408.
   PubMedGoogle Scholar
• Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999, 274, 26563–26571.
   PubMed Web of Science ®Google Scholar
• Frémin C, Ezan F, Boisselier P, Bessard A, Pagès G, Pouysségur J, Baffet G. ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology 2007, 45, 1035–1045.
   PubMed Web of Science ®Google Scholar
• Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J Am Coll Surg 2004, 198, 410–421.
   PubMedGoogle Scholar
• Bessard A, Frémin C, Ezan F, Coutant A, Baffet G. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. J Cell Physiol 2007, 212, 526–536.
   Google Scholar
• Liu X, Yan S, Zhou T, Terada Y, Erikson RL. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 2004, 23, 763–776.
   PubMedGoogle Scholar
• Shama J, Garcia-Medina R, Pouyssegur J, Vial E. Major contribution of MEK1 to the activation of ERK1/ERK2and to the growth of LS174T colon carcinoma cells. Biochem Bioph Res Co 2008, 372, 845–849.
   PubMedGoogle Scholar
• Lefloch R, Pouysségur J, Lenormand P. Single and combined silencing of ERK1 and ERK2reveals their positive contribution to growth signaling depending on their expression levels. Mol Cel Biol 2008, 28, 511–527.
   PubMed Web of Science ®Google Scholar
• Lawrence MC, Jivan A, Shao CL, Duan L, Goad D, Zaganjor E, Osborne J, McGlynn K, Stippec S, Earnest S, Chen W, Cobb MH. The roles of MAPKs in diease. Cell Res 2008, 18, 436–442.
   PubMed Web of Science ®Google Scholar
• Daoud G, Amyot M, Rassart E, Masse A, Simoneau L, Lafond J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol (Lond) 2005, 566, 409–423.
   Google Scholar
• Carthew RW. Gene silencing by double-stranded RNA. Curr Opin Cell Biol 2001, 13, 244–248.
   PubMed Web of Science ®Google Scholar
• Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002, 20, 446–448.
   PubMed Web of Science ®Google Scholar
• Sui G, Soohoo C, Affar EB, Gay F, Shi Y, Forrester WC, Shi Y. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002, 99, 5515–5520.
   PubMed Web of Science ®Google Scholar
• Tang F, Meng G, Yang H, Li CJ, Shi Y, Ding M, Shang KG, Zhang B, Xue Y. Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA. Stem Cell 2004, 22, 93–99.
   PubMedGoogle Scholar
• Novrino G. Involvement of the intracellular ion channel CLIC1 in microglia-mediated β-amyloid-induced neurotoxicity. J Neurosci 2004, 24, 5322–5330.
   PubMedGoogle Scholar